0 Comments
0 Shares
85 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Cardiovascular Drugs Market – SGLT2 Inhibitors Expanding Beyond Diabetes into Heart FailureMarket OverviewSGLT2 inhibitors are expanding beyond diabetes into heart failure and chronic kidney disease, reshaping the cardiovascular drugs market through a powerful cardiorenal treatment paradigm. These therapies reduce hospitalization for heart failure and slow kidney disease progression, leading guidelines to adopt them as foundational therapy across multiple indications. The...0 Comments 0 Shares 1K Views 0 Reviews
-
Orthostatic Hypotension Drugs Market Advances with Rising Demand for Targeted Therapies and Improved Cardiovascular CareAccording to the latest report published by Data Bridge Market Research, the Orthostatic Hypotension Drugs Market Data Bridge Market Research analyses that the orthostatic hypotension drugs market, which was USD 744.93 million in 2022, is expected to reach USD 1,313.81 million by 2030, at a CAGR of 7.35% during the forecast period 2023 to 2030. Winning Orthostatic Hypotension Drugs...0 Comments 0 Shares 2K Views 0 Reviews
-
Why Regional Analysis is Crucial for Understanding the Amlodipine Besylate MarketUnderstanding the regional dynamics of the Amlodipine Besylate Market is essential for stakeholders aiming to navigate its complexities. The market is projected to grow at a compound annual growth rate (CAGR) of 5.00%, reaching an estimated USD 0.6843 billion by 2035. This growth is driven by multiple factors, including the increasing prevalence of hypertension and the rising demand for...0 Comments 0 Shares 4K Views 0 Reviews